Sulfamerazine

Sulfamerazine, sulfamerazine, 127-79-7, Sulphamerazine, Sulfamethyldiazine, Mesulfa, 4-amino-N-(4-methylpyrimidin-2-yl)benzenesulfonamide, Percoccide, Benzenesulfonamide, 4-amino-N-(4-methyl-2-pyrimidinyl)-, Septacil, Septosyl, Solumedin, 2-Sulfa-4-methylpyrimidine, N-(4-Methyl-2-pyrimidyl)sulfanilamide, 2-(Sulfanilamido)-4-methylpyrimidine, 2-(4-Aminobenzenesulfonamido)-4-methylpyrimidine, 4-Amino-N-(4-methyl-2-pyrimidinyl)-benzenesulfonamide, (p-Aminobenzolsulfonyl)-2-amino-4-methylpyrimidin, DTXSID0023612, 4-amino-N-(4-methylpyrimidin-2-yl)benzene-1-sulfonamide, UR1SAB295F, NSC-27259, N(sup 1)-(4-Methyl-2-pyrimidinyl)sulfanilamide, CHEBI:102130, N(1)-(4-Methyl-2-pyrimidinyl)sulfanilamide, 2-(p-Aminobenzolsulfonamido)-4-methylpyrimidine, DTXCID603612, Methypyrimal, Sumedin, Monomethylsulfadiazine, RefChem:56065, SULFAMERAZINE FISH GRADE, 204-866-2, Methylsulfadiazine, Sulfamerazin, Cremomerazine, Methylpyrimal, Methylsulfazine, Sulfameradine, Pyralcid, Sumedine, Mebacid, Metilsulfadiazin, Veta-Merazine, Pyrimal M, Metilsulfazin, Sulfamerazina, Kelamerazine, Romezin, Debenal-M, Pirimal-M, Methylsulfazin, Sulfamerazinum, 2643-RP, RP 2632, N1-(4-Methyl-2-pyrimidinyl)sulfanilamide, A-310, 2-Sulfanilamido-4-methylpyrimidine, 4-Amino-N-(4-methyl-2-pyrimidinyl)benzenesulfonamide, NSC 27259, Sulfanilamide, N1-(4-methyl-2-pyrimidinyl)-, Solumedine, Sulfamerazine (INN), 2632 R. P., MFCD00023212, RP2632, MLS000551747, Solfamerazina, Sulfanilamide, N(sup 1)-(4-methyl-2-pyrimidinyl)-, NCGC00016386-01, CAS-127-79-7, SMR000145672, TRISULFAPYRIMIDINES (SULFAMERAZINE), Solfamerazina [DCIT], SULFAMERAZINE [INN], Sulfamerazinum [INN-Latin], Sulfamerazina [INN-Spanish], 4-Amino-N-(4-methyl-pyrimidin-2-yl)-benzenesulfonamide, 4-amino-N-(4-methylpyrimidin-2-yl), SR-01000684857, EINECS 204-866-2, UNII-UR1SAB295F, [(4-aminophenyl)sulfonyl](4-methylpyrimidin-2-yl)amine, BRN 0249133, ulfamerazine, AI3-08026, Sulfamerazine [USP:INN:BAN], (p-Aminobenzolsulfonyl)-2-amino-4-methylpyrimidin [German], Sulfamerazine CRS, Prestwick_17, 4-Amino-N-(4-methyl-2-pyrimidyl)benzenesulfonamide, Sulfamerazine, Sulfadimidine Imp. A (Pharmeuropa), Sulfadimidine Impurity A, 4-Methylsulfadiazine, , Spectrum_000003, N1-(4-Methylpyrimidin-2-yl)sulfanilamide, Opera_ID_988, Sulfamerazine (Standard), Prestwick0_000694, Prestwick1_000694, Prestwick2_000694, Prestwick3_000694, Spectrum2_001320, Spectrum3_001363, Spectrum4_000343, Spectrum5_001413, 2(p-Aminobenzolsulfonamido)-4-methylpyrimidin, SULFAMERAZINE [MI], CHEMBL438, Epitope ID:122236, N(sup1)-(4-Methyl-2-pyrimidinyl)sulfanilamide, Sulfadimidine EP Impurity A, SCHEMBL33999, BSPBio_000847, BSPBio_002886, KBioGR_000745, KBioSS_000343, SULFAMERAZINE [VANDF], 5-25-10-00167 (Beilstein Handbook Reference), MLS001201765, DivK1c_000563, SPECTRUM1500547, SULFAMERAZINE [MART.], SPBio_001419, SPBio_002768, SULFAMERAZINE [USP-RS], SULFAMERAZINE [WHO-DD], BPBio1_000933, orb1310174, orb3140134, SCHEMBL29538415, GTPL12640, HMS501M05, HY-B0512R, KBio1_000563, KBio2_000343, KBio2_002911, KBio2_005479, KBio3_002106, MSK4002, NINDS_000563, GLXC-08058, HMS1570K09, HMS1921A15, HMS2092I17, HMS2097K09, HMS2234D16, HMS3374K04, HMS3652I03, HMS3714K09, HMS5081G18, Pharmakon1600-01500547, SULFAMERAZINE [GREEN BOOK], SULFAMERAZINE [ORANGE BOOK], ALBB-025702, HY-B0512, NSC27259, 2-Sulfanilamido-4-methylpyrimidine, , SULFAMERAZINE [EP MONOGRAPH], Tox21_110411, BBL003544, CCG-39258, EBC-03812, MSK4002-100M, NSC757325, s3132, SBB057970, STK520614, SULFOSE COMPONENT SULFAMERAZINE, AKOS005143010, MSK4002-1000M, TERFONYL COMPONENT SULFAMERAZINE, Tox21_110411_1, DB01581, KS-5323, NSC-757325, IDI1_000563, LANTRISUL COMPONENT SULFAMERAZINE, pyrimidine, 4-methyl-2-sulphanilamido-, SULFALOID COMPONENT SULFAMERAZINE, NCGC00016386-02, NCGC00016386-03, NCGC00016386-06, NCGC00094787-01, NCGC00094787-02, NEOTRIZINE COMPONENT SULFAMERAZINE, FA133240, N'-(4-Methyl-2-pyrimidyl) sulfanilamide, SULFAMERAZINE (TRISULFAPYRIMIDINES), SBI-0051521.P003, DB-041873, Sulfamerazine, ReagentPlus(R), >=99.0%, AB00052096, NS00000004, ST45028776, Sulfamerazine 100 microg/mL in Acetonitrile, SW196334-3, T0913, TRIPLE SULFOID COMPONENT SULFAMERAZINE, SULFADIMIDINE IMPURITY A [EP IMPURITY], Sulfamerazine 1000 microg/mL in Acetonitrile, Sulfamerazine Solution in Methanol, 100ug/mL, Sulfamerazine, Vetec(TM) reagent grade, 98%, 2-(p-Aminobenzosulfonamido)-4-methylpyrimidine, D02435, D84140, EN300-202655, Sulfamerazine Solution in Methanol, 1000ug/mL, AB00052096-13, AB00052096_15, AB00052096_16, F375115, Q415196, Sulfamerazine, VETRANAL(TM), analytical standard, SR-01000684857-2, SR-01000684857-4, BRD-K93524252-001-05-6, BRD-K93524252-001-15-5, BRD-K93524252-001-23-9, BRD-K93524252-001-24-7, F2190-0484, N(SUP 1)-(4-METHYL-2- PYRIMIDINYL)SULFANILAMIDE, TRISULFAPYRIMIDINES (SULFAMERAZINE) [ORANGE BOOK], Z1954804578, benzenesulfonamide, 4-amino-N(S)-(4-methylpyrimidin-2-yl)-, Sulfamerazine, European Pharmacopoeia (EP) Reference Standard, Sulfamerazine, United States Pharmacopeia (USP) Reference Standard, Sulfamerazine, Pharmaceutical Secondary Standard, Certified Reference Material